Publications – KalVista Pharmaceuticals

Showing 1-10 out of 39

Sebetralstat for On-demand Treatment of Hereditary Angioedema Attacks: Results of the Double-blind, Placebo-controlled, Phase 3 KONFIDENT Trial

Reidl MA, Aygören-Pürsün E, Lumry WR, Farkas H, Zanichelli A, Hao J, Iverson M, Smith MD, Yea CM, Audhya PK, Bernstein JA, Maurer M, Cohn DM

CIIC 2024

Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema

Feener EP, Davie RL, Murugesan N, Pethen SJ, Hampton SL, Smith MD, Audhya PK, Yea CM

Drugs and Drug Candidates

POSTER & SUPPLEMENT: Sebetralstat for On-demand Treatment of Hereditary Angioedema Attacks: Results of the Double-blind, Placebo-controlled Phase 3 KONFIDENT Trial

Marc A. Riedl, Emel Aygören-Pürsün, William R. Lumry, Henriette Farkas, Andrea Zanichelli, James Hao, Matthew Iverson, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Jonathan A. Bernstein, Marcus Maurer, Danny M. Cohn

AAAAI 2024

KONFIDENT Phase 3 Trial Global Expansion: Sebetralstat Pharmacokinetics and Pharmacodynamics in Japanese and Chinese Adults

Honda D, Iverson M, Hansen E, Hampton SL, Jhee S, Yoon E, Audhya PK, Smith MD, Yea CM, Hide M

APAAACI 2023

Investigating On-Demand Use of Oral Sebetralstat in Adults and Adolescents With Hereditary Angioedema: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 KONFIDENT Trial and Open-Label Extension Designs

Hide M, Audhya PK, Smith MD, Yea CM

JSA 2023

Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat

Cohn DM, Aygören-Pürsün E, Bernstein JA, Farkas H, Lumry WR, Maurer M, Zanichelli A, Iverson M, Hao J, Smith MD, Yea CM, Audhya PK, Riedl MA

2023 Clinical and Translation Allergy

Sebetralstat, Investigational Oral On-Demand Treatment for HAE: KONFIDENT Trial Design

Aygören-Pürsün E, Zanichelli A, Cohn DM, Farkas H, Bernstein JA, Audhya PK, Smith MD, Yea CM, Lumry WR, Riedl MA, Maurer M

IWAA 2023

Short-Term Prophylaxis With Sebetralstat, an Investigational Oral On-Demand Treatment for Hereditary Angioedema, in KONFIDENT-S

Bernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM

IWAA 2023

Short-Term Prophylaxis with Sebetralstat, an Investigational Oral On-Demand Treatment for Hereditary Angioedema, in KONFIDENT-S

Bernstein JA, Riedl MA, Lumry WR, Audhya PK, Smith MD, Yea CM

EAACI 2023

Results From a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial Evaluating Sebetralstat Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability in Healthy Japanese, Chinese, and White Adults

Hide M, Iverson M, Jhee S, Hansen E, Duckworth EJ, Hampton SL, Yoon E, Honda D

EAACI 2023

About

Science

Pipeline

Careers

Contact